Portal de Periódicos da CAPES

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents

2000; Wiley; Volume: 39; Issue: 6 Linguagem: Inglês

10.1046/j.1365-4362.2000.00964.x

1365-4632

Aditya K. Gupta, J.Q. Del Rosso,

Cutaneous lymphoproliferative disorders research

International Journal of DermatologyVolume 39, Issue 6 p. 401-411 An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents Aditya K. Gupta, Aditya K. Gupta Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authormd , md Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authorJames Q. Del Rosso, James Q. Del Rosso Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authordo , do Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this author Aditya K. Gupta, Aditya K. Gupta Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authormd , md Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authorJames Q. Del Rosso, James Q. Del Rosso Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this authordo , do Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), and the University of Toronto, Toronto, Canada, and Department of Dermatology, University of Nevada, School of Medicine, Las Vegas, NevadaSearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1365-4362.2000.00964.xCitations: 30 Correspondence, Aditya K. Gupta, md, 490 Wonderland Road South, Suite 6, London, Ontario, Canada N6K 1L6. E-mail: agupta@execulink.comDrug namesfluconazole: Diflucangriseofulvin: Fulvicin, Grifulvin, Grisactin, Gris-PEGitraconazole: Sporanoxketoconazole: Nizoralterbinafine: Lamisil Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume39, Issue6June 2000Pages 401-411 RelatedInformation